Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

300 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunogenicity, safety, and reactogenicity of a half- versus full-dose BNT162b2 (Pfizer-BioNTech) booster following a two-dose ChAdOx1 nCoV-19, BBIBP-CorV, or Gam-COVID-Vac priming schedule in Mongolia: a randomised, controlled, non-inferiority trial.
Batmunkh T, Moore KA, Thomson H, Altangerel B, Amraa O, Avaa N, Batbayar L, Batsukh K, Bright K, Burentogtokh T, Ha Do LA, Dorj G, Hart JD, Javkhlantugs K, Jigjidsuren S, Justice F, Li S, Licciardi PV, Mashbaatar K, Mazarakis N, Neal EFG, Nguyen CD, Ochirbat B, Tsolmon B, Tuya A, Surenjav U, von Mollendorf C, Mulholland K. Batmunkh T, et al. Among authors: mulholland k. Lancet Reg Health West Pac. 2023 Nov 21;42:100953. doi: 10.1016/j.lanwpc.2023.100953. eCollection 2024 Jan. Lancet Reg Health West Pac. 2023. PMID: 38357398 Free PMC article.
Immunogenicity and safety in healthy adults of full dose versus half doses of COVID-19 vaccine (ChAdOx1-S or BNT162b2) or full-dose CoronaVac administered as a booster dose after priming with CoronaVac: a randomised, observer-masked, controlled trial in Indonesia.
Fadlyana E, Setiabudi D, Kartasasmita CB, Putri ND, Rezeki Hadinegoro S, Mulholland K; BCOV21 study group. Fadlyana E, et al. Among authors: mulholland k. Lancet Infect Dis. 2023 May;23(5):545-555. doi: 10.1016/S1473-3099(22)00800-3. Epub 2023 Jan 11. Lancet Infect Dis. 2023. PMID: 36640798 Clinical Trial.
Impact of COVID-19 Nonpharmaceutical Interventions on Pneumococcal Carriage Prevalence and Density in Vietnam.
Nation ML, Manna S, Tran HP, Nguyen CD, Vy LTT, Uyen DY, Phuong TL, Dai VTT, Ortika BD, Wee-Hee AC, Beissbarth J, Hinds J, Bright K, Smith-Vaughan H, Nguyen TV, Mulholland K, Temple B, Satzke C. Nation ML, et al. Among authors: mulholland k. Microbiol Spectr. 2023 Feb 14;11(1):e0361522. doi: 10.1128/spectrum.03615-22. Epub 2023 Jan 16. Microbiol Spectr. 2023. PMID: 36645282 Free PMC article.
Effect of different schedules of ten-valent pneumococcal conjugate vaccine on pneumococcal carriage in Vietnamese infants: results from a randomised controlled trial.
Smith-Vaughan H, Temple B, Trang Dai VT, Hoan PT, Loc Thuy HN, Phan TV, Bright K, Toan NT, Uyen DY, Nguyen CD, Beissbarth J, Ortika BD, Nation ML, Dunne EM, Hinds J, Lai J, Satzke C, Huu TN, Mulholland K. Smith-Vaughan H, et al. Among authors: mulholland k. Lancet Reg Health West Pac. 2022 Dec 3;32:100651. doi: 10.1016/j.lanwpc.2022.100651. eCollection 2023 Mar. Lancet Reg Health West Pac. 2022. PMID: 36785850 Free PMC article.
Efficacy against pneumococcal carriage and the immunogenicity of reduced-dose (0 + 1 and 1 + 1) PCV10 and PCV13 schedules in Ho Chi Minh City, Viet Nam: a parallel, single-blind, randomised controlled trial.
Temple B, Tran HP, Dai VTT, Smith-Vaughan H; VPT-II Collaborator Group; Licciardi PV, Satzke C, Nguyen TV, Mulholland K. Temple B, et al. Among authors: mulholland k. Lancet Infect Dis. 2023 Aug;23(8):933-944. doi: 10.1016/S1473-3099(23)00061-0. Epub 2023 Apr 14. Lancet Infect Dis. 2023. PMID: 37062304 Free PMC article. Clinical Trial.
A single dose of quadrivalent HPV vaccine is highly effective against HPV genotypes 16 and 18 detection in young pregnant women eight years following vaccination: an retrospective cohort study in Fiji.
Reyburn R, Tuivaga E, Ratu T, Young S, Garland SM, Murray G, Cornall A, Tabrizi S, Nguyen CD, Jenkins K, Tikoduadua L, Kado J, Kama M, Rafai E, Devi R, Mulholland K, Fong J, Russell FM. Reyburn R, et al. Among authors: mulholland k. Lancet Reg Health West Pac. 2023 Jun 14;37:100798. doi: 10.1016/j.lanwpc.2023.100798. eCollection 2023 Aug. Lancet Reg Health West Pac. 2023. PMID: 37359996 Free PMC article.
Evaluation of the effect of reduced-dose pneumococcal conjugate vaccine schedules on vaccine serotype carriage in children and their caretakers in a naïve population in Vietnam: Protocol for a cluster randomized non-inferiority trial.
Yoshida LM, Flasche S, Mulholland K, Nguyen HA, Nguyen C, Toizumi M, Dang DA. Yoshida LM, et al. Among authors: mulholland k. Gates Open Res. 2023 Jul 20;7:110. doi: 10.12688/gatesopenres.14742.1. eCollection 2023. Gates Open Res. 2023. PMID: 37780234 Free PMC article.
Impact of pneumococcal conjugate vaccine 13 introduction on severe lower respiratory tract infections associated with respiratory syncytial virus or influenza virus in hospitalized children in Ulaanbaatar, Mongolia.
Do LAH, Tsedenbal N, Khishigmunkh C, Tserendulam B, Altanbumba L, Luvsantseren D, Ulziibayar M, Suuri B, Narangerel D, Tsolmon B, Demberelsuren S, Nguyen C, Mungun T, von Mollendorf C, Badarch D, Mulholland K. Do LAH, et al. Among authors: mulholland k. IJID Reg. 2024 Mar 19;11:100357. doi: 10.1016/j.ijregi.2024.100357. eCollection 2024 Jun. IJID Reg. 2024. PMID: 38577554 Free PMC article.
300 results